CBT found to be effective in treating binge eating disorders in adolescents


A study published in Psychotherapy and Psychosomatics found cognitive behavioral therapy to be effective, in treating binge eating disorder in adolescence, with lasting results.

Binge-eating disorder, characterized by recurrent episodes of uncontrolled eating that occurs in the absence of compensatory behaviors to prevent weight gain, is the most common eating disorder emerging in adolescence. Cognitive-behavioral therapy (CBT) represents the most well-established treatment for adults with binge eating disorder. Only few pilot studies have been conducted to evaluate the efficacy of CBT in treating binge eating disorders in adolescents. These studies suggested superiority of CBT compared to waiting list in achieving binge-eating abstinence and in improving eating disorder psychopathology.

The BEDA study was conducted to provide a confirmatory test of the efficacy of age adapted cognitive behavioral therapy in adolescent with binge eating disorder. Seventy-three adolescents (82% girls) were randomized to receive CBT or waiting list. Results showed that adolescents receiving CBT had 5 fewer monthly binge-eating episodes compared to adolescents in the waiting list condition. In addition, adolescents receiving CBT reported higher rates of abstinence from binge eating and remission from binge eating disorder. More important, after CBT, binge-eating episodes remained significantly reduced at 6-, 12-, and 24-month follow-up when compared with baseline.

This confirmatory study uniquely established the efficacy of CBT in improving binge-eating symptomatology and demonstrated long-term maintenance of effects over 24 months in adolescents with an age-adapted diagnosis of binge eating disorder.

Journal reference:

Hilbert, A., et al. (2020) Cognitive-Behavioral Therapy for Adolescents with an Age-Adapted Diagnosis of Binge-Eating Disorder: A Randomized Clinical Trial. Psychotherapy and Psychosomatics. doi.org/10.1159/000503116.

Articles You May Like

Why doesn’t migraine appear on an MRI? Ask Mayo Clinic
FDA Approves Zynyz (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)
How to Get into Medical School with a Low GPA #SHORTS
10 enriching things to try in April to benefit your wellbeing
Holy Smoke: Air Pollution Link to Bone Damage Confirmed

Leave a Reply

Your email address will not be published. Required fields are marked *